Duc H. Nguyen

发表

Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice

J. Mackay, S. Turville, W. Britton, 2022, Nature Communications.

Th2 cytokine antagonists: potential treatments for severe asthma

P. Foster, P. Allen, G. Kaiko, 2013, Expert opinion on investigational drugs.

Programmed Death Ligand 1 Promotes Early-Life Chlamydia Respiratory Infection-Induced Severe Allergic Airway Disease.

R. Kim, P. Hansbro, H. Yagita, 2016, American journal of respiratory cell and molecular biology.

PD-L1 promotes early-life chlamydia respiratory infection-induced severe allergic airway disease

R. Kim, P. Hansbro, H. Yagita, 2016 .

A pathogenic role for tumor necrosis factor-related apoptosis-inducing ligand in chronic obstructive pulmonary disease

Duc H. Nguyen, I. Adcock, P. Foster, 2015, Mucosal Immunology.

Tumor necrosis factor-related apoptosis-inducing ligand translates neonatal respiratory infection into chronic lung disease

P. Foster, R. Kim, P. Hansbro, 2013, Mucosal Immunology.

Constitutive production of IL-13 promotes early-life Chlamydia respiratory infection and allergic airway disease

P. Foster, R. Kim, P. Hansbro, 2012, Mucosal Immunology.

Chlamydia muridarum Lung Infection in Infants Alters Hematopoietic Cells to Promote Allergic Airway Disease in Mice

C. Mackay, H. Schilter, R. Kim, 2012, PloS one.

IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis

D. Sin, I. Adcock, P. Foster, 2019, European Respiratory Journal.

Increased SARS-CoV-2 Infection, Protease, and Inflammatory Responses in Chronic Obstructive Pulmonary Disease Primary Bronchial Epithelial Cells Defined with Single-Cell RNA Sequencing

Linden J. Gearing, P. Hertzog, P. Pathinayake, 2022, American journal of respiratory and critical care medicine.